- Poster presentation
- Open Access
Quantitative non-contrast T1 mapping of left ventricle in children and young adults
© Parekh et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Cardiac Magnetic Resonance
- Short Axis
- Cardiac Dysfunction
- Hypertrophic Cardiomyopathy
- Myocardial Fibrosis
Quantification of myocardial T1 values is a promising tool that may be used to quantify myocardial fibrosis. The purpose of our study is to establish a preliminary reference value of normal left ventricular (LV) myocardium in children and young adults using non-contrast T1 mapping.
The HIPAA compliant prospective study was IRB approved. Sixteen patients (mean age 15.4 years; range 5-25 years) underwent cardiac magnetic resonance (CMR) (1.5-T) including non-contrast short axis T1 mapping (modified Look-Locker [MOLLI] sequence). Twelve patients with no intrinsic myocardial abnormality based on clinical history, standard biomarkers and echocardiographic criteria were compared with 3 patients having cardiac dysfunction and 1 patient with hypertrophic cardiomyopathy (HCM). Short axis images were manually contoured to outline the epicardium and endocardium using AHA 16-segment model yielding 192 normal myocardial segments, 48 segments in patients with cardiac dysfunction, and 16 segments in a patient with HCM. Patient groups were compared using one-way analysis of co-variance (ANOVA). Chi-squared test was performed to compare appropriateness of discrete data. Receiver operating characteristic (ROC) curve was used to obtain a cut-off value of T1 relaxation time. Statistical significance was defined as p < 0.05.
Myocardial T1 values in the normals (982.1 ± 30.0 ms) were significantly different (p < 0.001) when compared to patients with cardiac dysfunction (1021.0 ± 34.8 ms) and hypertrophic cardiomyopathy (1039.7 ± 20.8 ms). Non-contrast myocardial T1 cutoff of 1005 ms conceded a sensitivity of 80% and specificity of 83% when compared to patients with cardiomyopathy (p < 0.001).
The normal non-contrast T1 values of LV myocardium in children and young adults obtained can be used as a baseline for comparison to patients with underlying myocardial abnormalities. Enrollment is underway to validate our results in a larger cohort.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.